S02 E21: Big pharma vs biotech and the future of marketing
In an interview double bill, Helena and Marc are joined two fantastic guests from the worlds of pharma marketing and commercial affairs. Michele Manto, Chief Commercial Officer, Galapagos, shares his thoughts on the differences in leading a large pharma company and an agile biotech, amongst other exciting topics, while Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk, talks all things marketing with insights into developing campaigns.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech
Time to turn to TikTok https://www.emg-gold.com/post/time-to-turn-to-tiktok
Bridging the digital health divide https://www.emg-gold.com/post/bridging-the-digital-health-divide
The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change